You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Review
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Authors

  • Puyuan Xing Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 17 Pan-jia-yuan South Lane, Chaoyang District 100021 Beijing China PubMed articlesGoogle scholar articles
  • Fan Zhang The Department of OncologyChinse PLA General Hospital Beijing China PubMed articlesGoogle scholar articles
  • Guoqiang Wang The Medical Department3D Medicines Inc Shanghai People’s Republic of China PubMed articlesGoogle scholar articles
  • Yu Xu The Medical Department3D Medicines Inc Shanghai People’s Republic of China PubMed articlesGoogle scholar articles
  • Chengcheng Li The Medical Department3D Medicines Inc Shanghai People’s Republic of China PubMed articlesGoogle scholar articles
  • Shouzheng Wang Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 17 Pan-jia-yuan South Lane, Chaoyang District 100021 Beijing China PubMed articlesGoogle scholar articles
  • Yiying Guo Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 17 Pan-jia-yuan South Lane, Chaoyang District 100021 Beijing China PubMed articlesGoogle scholar articles
  • Shangli Cai The Medical Department3D Medicines Inc Shanghai People’s Republic of China PubMed articlesGoogle scholar articles
  • Yan Wang Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 17 Pan-jia-yuan South Lane, Chaoyang District 100021 Beijing China PubMed articlesGoogle scholar articles
  • Junling Li Department of Medical OncologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 17 Pan-jia-yuan South Lane, Chaoyang District 100021 Beijing China PubMed articlesGoogle scholar articles
  1. ↵j lijunling{at}cicams.ac.cn
View Full Text

Citation

Xing P, Zhang F, Wang G, et al
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
Journal for ImmunoTherapy of Cancer 2019;7:341. doi: 10.1186/s40425-019-0779-6

Publication history

  • Received June 28, 2019
  • Accepted October 22, 2019
  • First published December 4, 2019.
Online issue publication 
December 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.